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Muscle wasting in chronic renal failure is associated with
increased morbidity and mortality; however, resistance
exercise is effective at increasing muscle mass while
improving muscle strength and function. To study the
mechanism by which this occurs, we compared uremic and
control rats where work overload was surgically induced
unilaterally in the plantaris muscle. We found that work
overload increases muscle insulin-like growth factor-1 and
mechano-growth factor expression. This in addition to direct
mechanical activation of signaling was likely the cause of the
observed increased in the protein levels and phosphorylation
of the mediators of these growth factors, the insulin receptor
substrate-1/phosphoinositide 3-kinase/Akt pathway. The
mechanical enhancement of signal transduction appeared to
be mediated in part by increased signal protein levels and
decreased SOCS2 mRNA expression (suppressor of cytokine
signaling-2). Despite impaired basal signaling, the
work-induced signaling response was similar to that
observed in nonuremic rats and produced changes
consistent with decreased muscle protein degradation,
increased protein synthetic capacity, and an increased
number of multinucleated muscle cells. Our studies suggest
that these work-induced changes account for the improved
uremic muscle mass reaching levels comparable to those
seen in normal rats.
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Muscle wasting in chronic disease states is associated with an
increase in morbidity and mortality, and this is also true for
chronic renal failure (CRF).1 Several processes operative in
uremia contribute to the loss of muscle mass by affecting
protein turnover. These include reduced nutrient intake,
physical inactivity, acidosis, inflammation, and sepsis. Also
important is resistance to and/or deficiencies of anabolic
hormones such as growth hormone (GH), insulin-like
growth factor-1 (IGF-1),2 and insulin, which are worsened
by undernutrition and inflammation.3 These perturbations
lead to an increase in proteolysis, largely but not only because
of activation of the ubiquitin–proteasome system,4 while
protein synthesis may also be diminished.5,6 Maneuvers to
correct muscle wasting have included anabolic hormone
therapy,3,7 optimization of nutritional intake and acid–base
balance, and exercise. Resistance exercise in particular is
effective in increasing muscle mass, and improving strength
and function.7 The mechanism whereby resistance exercise
induces muscle growth in uremia is poorly understood,
although a change in balance between local IGF-1 and
myostatin appears to be important.8
In general, IGF-1 plays a key role in promoting muscle
growth, repair, and maintenance of mass.9–11 IGF-1 is
synthesized throughout the body under the influence of
GH with liver as the main source of circulating hormone.12
In skeletal muscle, expression of IGF-1, including the splice
variant mechano-growth factor (MGF), is also regulated by
mechanical stimuli induced by exercise independent of
GH13,14 and plays a key role in exercise-induced muscle
hypertrophy.9,10 Indeed, in an earlier study of uremic rats, we
showed that functional overload effectively stimulated total
IGF-1 expression, despite resistance to GH-induced IGF-1
expression;8 MGF expression was not measured. This
response provides one mechanism for the beneficial effects
of exercise in CRF patients.1,15,16 In end-stage renal disease,
skeletal muscle IGF-1 and IGF-1 receptor mRNA levels are
reported to be reduced17 and in patients with muscle wasting
IGF-1 peptide levels are low, even when serum levels are
unchanged.18 Generally, serum IGF-1 levels are normal or
even elevated in adults with end-stage renal disease,17,18 but
are reduced in the severely malnourished. Also, muscle IGF-1
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peptide levels are reduced in wasted subjects,18 but may be
increased in relatively well-nourished patients.17
Apart from any local muscle IGF-1 deficiency present in
uremia,17,18 resistance to IGF-1 (and insulin) also predisposes
to wasting and arises partly because of impaired signaling
through the insulin receptor substrate-1 (IRS-1)/phospho-
inositide 3-kinase (PI3-kinase)/Akt signaling pathway.2,19 Akt
activation leads to mTOR phosphorylation that then
activates the 70-kDa ribosomal S6 kinase (p70S6K), even-
tually leading to increased protein synthesis.20,21 Another
important Akt substrate is glycogen-synthase kinase 3b, an
inhibitor of protein translation suppressed by Akt, and this
response also leads to increased protein synthesis. It is
noteworthy that the signaling pathways through which IGF-1
stimulates muscle growth are similar to those activated by
mechanical stimuli alone, and it is difficult to distinguish
between these two stimuli, especially as mechanical stimula-
tion leads to a local increase in IGF-1.10,22 Both mechanical
and IGF-1-induced activation of the Akt/mTOR pathway are
essential for promoting muscle growth and repair.10,21,23,24
The activated PI3-kinase/Akt pathway also inhibits the
transcription of atrophy-related ubiquitin ligases, atrogin-1/
MAFbx and MuRF-1, and activation of caspase-3, thereby
suppressing proteolysis mediated through the ubiquitin–
proteasome pathway,4,25–27 which is hyperactive in the
acidotic uremic state.28 Caspases cleave complex proteins,
such as myofibrillar proteins, into smaller products that are
rapidly degraded via the ubiquitin–proteasome system.4 In
CRF and other catabolic conditions, caspase-3 activity is
increased because of suppressed PI3-kinase/Akt signaling;
actomyosin cleavage is accelerated, and formation of a
14-kDa actin fragment, a marker of muscle proteolysis, is
increased.4,29
In this study of muscle wasting and recovery in uremic
rats, we aimed to characterize the mechanisms whereby
resistance exercise increases muscle mass, despite impaired
signaling through the IRS-1/PI3-kinase/Akt pathway and
insensitivity to IGF-1. We tested the hypothesis that work
overload (WO)-induced local production of IGF-1 together
with mechanically activated signal transduction are capable
of overriding the defect in signal transduction, and this leads
to suppression of accelerated proteolysis, an increase in
protein synthetic capacity, and also cellular proliferation that
together lead to an increase in muscle mass.
RESULTS
Serum biochemistry and anthropometrics
After 21 days of CRF, serum creatinine and urea nitrogen
levels were increased significantly compared with the sham-
nephrectomized (SN) values (Table 1). In contrast, serum
bicarbonate levels were similar.
Work overload increases the mass of atrophied skeletal
muscle
In CRF rats, nonloaded control plantaris muscle weight was
significantly lower than the weight of the corresponding
muscle of SN rats (Table 1). WO promoted a significant
increase in muscle weight in both groups (Table 1) and after
7 days the CRF muscle weight had increased to reach a level
similar to that of the WO SN muscle.
Muscle mRNA levels
Total IGF-1 and MGF mRNA levels were similar in the
nonloaded control plantaris muscle of both groups (Figure 1a).
Following 7 days of WO, total IGF-1 mRNA levels increased
significantly and to a similar extent. MGF levels also rose, and
though the average increase was less in the CRF group, it did
not differ significantly from the SN value. As we described
before,8 basal suppressor of cytokine signaling-2 (SOCS2) mRNA
levels were elevated significantly in the uremic muscle (153%
of SN value; Figure 1b). Of note, the increase in workload
suppressed the SOCS2 levels to values seen in nonloaded
muscles of SN animals. This SOCS is of particular interest as it
Table 1 | Biochemical and anthropometric characteristics of
SN and CRF rats
SN CRF
Number of rats 9 13
Serum creatinine (mg per 100 ml) 0.40±0.04 1.28±0.08**
Serum urea nitrogen (mg per 100 ml ) 17±2 68±4**
Serum bicarbonate (mmol l1) 22±0.69 23±1.02
Body weight (g) 313±2 299±5
Control plantaris weight (mg) 381±9 338±10**
WO plantaris weight (mg) 439±24# 423±29##
CRF, chronic renal failure; SN, sham-nephrectomized; WO, work overload.
**Po0.01, CRF vs SN; #Po0.05; and ##Po0.01, WO vs control.
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Figure 1 | WO increased plantaris muscle IGF-1, MGF, and SOCS3
mRNA levels in CRF and SN rats and depressed elevated SOCS2
mRNA levels in CRF. Plantaris muscles from both limbs were
collected after 7 days of unilateral WO. mRNA levels were measured
by real-time PCR and corrected for the internal housekeeping gene
18S. Results are mean±s.e.m. from eight muscles per group, were
expressed relative to the values obtained from the nonloaded control
plantaris muscle of the SN group, and assigned a mean value of 100.
*Po0.05, CRF vs SN; #Po0.05 and ##Po0.01 WO vs control.
Kidney International (2008) 73, 848–855 849
Y Chen et al.: Exercise-induced signal transduction in uremia o r i g i n a l a r t i c l e
not only inhibits GH signaling and thus IGF-1 expression,30,31
but may also inhibit IGF-1 signaling.32 SOCS3, another
negative regulator of GH30 and insulin/IGF-1 signaling33
known to increase following exercise,34 was unaltered in CRF
rats and following an increase in workload rose to a similar
extent in CRF and SN muscles (Figure 1b). Interestingly, there
was no difference in the mRNA levels of the E3 ubiquitin-
conjugating enzymes atrogin-1/MAFbx and MuRF-1, in the
nonloaded plantaris muscle of CRF compared with SN rats
(Table 2). Following WO, there was a small nonsignificant
decline in atrogin-1/MAFbx expression. MuRF-1 expression
declined significantly in SN rat muscle, but the decline did not
reach significance in CRF rat muscle.
Signaling protein levels
In CRF rats, the levels of signaling proteins involved in the
PI3-kinase/Akt pathway in nonloaded control plantaris
muscle were similar to the SN values (Figure 2a and b).
Although the IRS-1 level in the CRF group averaged 55% of
SN value, statistical significance was not reached because of
variability. WO of plantaris muscle of SN rats induced a
significant increase in several signaling proteins including the
IGF-1 receptor, IRS-1, Akt, mTOR, and p70S6K proteins,
while p85 levels were unchanged (Figure 3a and b). A similar
pattern was observed in CRF rats (Figure 3b). Although to
our knowledge IGF-1 alone does not cause such an increase
in signaling protein levels, this increase likely reflects a direct
response to mechanical stimulation.
Levels of phosphorylated signaling proteins
Of note, basal phospho-IRS-1 and phospho-Akt-1 levels in
nonloaded control muscle of CRF rats were significantly
reduced compared with the SN values; phosphorylation of
other signaling proteins did not differ significantly (Figure 4a
and c). These observations are consistent with the reduced
basal IRS-1-associated PI3-kinase activity and phospho-Akt
levels noted by Bailey et al.,19 which they interpreted as
reflecting uremia-mediated insulin/IGF-1 resistance. The Akt
phosphoprotein/protein ratio (Figure 4b), a measure of
phosphorylation efficiency, was reduced significantly in CRF
muscle and accounts for the low phospho-Akt levels seen
despite normal protein levels (Figure 2). In contrast, the
IRS-1 phosphoprotein/protein ratio was unchanged, indicat-
ing that the reduced phospho-IRS-1 level was a consequence
of reduced IRS-1 protein expression. WO activated the
phosphorylation of several signaling proteins in SN plantaris
muscle (Figure 5a). In particular, phospho-IRS-1, phospho-
Akt, phospho-mTOR, and phospho-p70S6K increased signi-
ficantly. Interestingly, the efficiency of phosphorylation of
AKT and p70S6K increased, while that of IGF-1R/IR
Table 2 | Atrogin-1/MAFbx and MuRF-1 mRNA expression in
nonloaded controls (Con), and work-overloaded (WO)
plantaris muscle in SN and CRF rats
SN-Con SN-WO CRF-Con CRF-WO
Atrogin-1/MAFbx 100±7 79±24 98±14 78±12
MuRF-1 100±15 45±8## 78±4 58±6
CRF, chronic renal failure; SN, sham-nephrectomized.
Specific mRNA levels were normalized for the internal control gene 18S RNA and are
expressed as transcript/housekeeping gene ratios.
##Po0.01 WO vs control.
SN200
Pr
ot
ei
n 
le
ve
ls
 
(%
 S
N)
150
100
50
0
CRF
IGF-1R
IGF-1R
IRS-1
IRS-1
SN CRF
p85
p85
Akt
Akt
mTOR p70S6K
mTOR
p70S6K (70 kDa)
Actin (42 kDa)
Figure 2 | Signaling protein levels in nonloaded control plantaris
muscle of SN and CRF rats were not significantly different.
(a) Protein values were expressed as a percentage of SN control mean
(n¼ 6 per group). (b) Western immunoblots of selected proteins of
pooled samples from all animals in each group run in duplicate.
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Figure 3 | Signaling protein levels in nonloaded control and
work-overloaded plantaris muscle of SN rats. Work overload (WO)
induced a significant increase in several signaling proteins. (a) Mean
and s.e.m. of individual protein values were expressed as a
percentage of the SN control plantaris muscle mean. #Po0.05 and
##Po0.01 WO vs control. (b) Western immunoblots of proteins in
pooled samples of all control or WO muscles from SN and CRF
rats run in duplicate.
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decreased (Figure 5b). This decreased efficiency was com-
pensated for by the increase in receptor protein levels
(Figures 3 and 5a). In CRF rats, sustained WO also activated
phosphorylation of the same signaling proteins and to a
similar level as in SN rats (Figure 5c). Taken together this
indicates that sustained WO can overcome signaling defects
present in uremia and effectively activate signaling along the
PI3-kinase/Akt pathway.
14-kDa actin fragment levels in skeletal muscle
The 14-kDa actin fragment was increased nearly fourfold in
the nonloaded plantaris muscle of CRF rats compared with
the SN normal rats (366±23 vs 100±34 relative units,
Po0.02). This is consistent with an increase in proteolysis as
a cause of muscle wasting in uremia.27 Furthermore, WO
significantly reduced the high actin fragment level in CRF
muscle to a value that did not differ significantly from SN
control values (Figure 6).
Muscle total RNA and DNA levels
Following an increase in workload, total muscle RNA content
increased significantly in both SN and CRF rats. This
parameter serves as an indirect measure of total tissue
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Figure 4 | Basal levels of phosphorylated signaling proteins in
control nonloaded plantaris muscle of SN and CRF rats.
(a) phospho-IRS-1 and phospho-Akt levels were significantly reduced
in CRF rats. Mean and s.e.m. of individual phosphoprotein levels were
expressed as a percentage of the average SN control value.
(b) Relative phosphoprotein levels. Phosphoprotein levels corrected
for specific protein levels were expressed as a percentage of mean SN
value. *Po0.05 CRF vs SN. (c) Western immunoblots of selected
phosphoproteins in pooled samples from all animals in each group
run in duplicate.
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Figure 5 | Phosphorylated signaling protein levels in control
nonloaded and WO plantaris muscle of SN and CRF rats.
(a) Phosphoprotein levels in control and WO plantaris muscles of SN
group. Mean and s.e.m. of individual values were expressed as a
percentage of the SN control plantaris muscle mean. (b) Relative
phosphoprotein levels. #Po0.05 and ##Po0.01 WO vs control.
(c) Western immunoblots of selected phosphoproteins in pooled
samples of all plantaris muscles in each group run in duplicate.
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Figure 6 | Western immunoblot of the 14-kDa actin fragment in
control and work-overloaded plantaris muscle of CRF and SN
rats. Fragment levels increased in CRF then decreased following an
increase in workload. Samples consisted of duplicate pooled extracts
from each group.
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ribosomal content and protein translational capacity.35,36 In
SN rats, RNA content increased from 142±10 to 317±39 mg
per muscle, Po0.01. In CRF rats, RNA content increased
from 119±6 to 267±43 mg per muscle, Po0.01, a value that
did not differ significantly from that after an increase in
workload in SN rats. Similarly, plantaris muscle DNA
content, a reflection of myonuclear content,37 increased after
an increase in workload. In SN rats, DNA content rose from
29±4 to 60±12 mg per muscle, Po0.01. In CRF rats, DNA
content increased from 25±3 to 49±6 mg per muscle,
Po0.05; a level that did not differ statistically from the SN
value. These findings are consistent with a work-induced
increase in protein synthetic capacity35,36 and proliferation of
satellite cells37 that appear to be unimpeded by uremia.
DISCUSSION
Regulation of muscle mass is to a large extent mediated
through the PI3-kinase/Akt pathway in response to IGF-1,
insulin, and mechanical stimuli.10,22,23 In CRF rats, impaired
transduction through the IRS-1/PI3-kinase/Akt pathway2,19
leads to IGF-1/insulin resistance, an increase in protein
degradation,1,4 decreased protein synthesis, and loss of
muscle mass.2,19 Fortunately, despite impaired signaling,
resistance exercise is effective in treating uremic muscle
wasting.38 As we reported earlier,8 this occurs in part through
a change in the balance between IGF-1 and myostatin, an
inhibitor of muscle growth; WO stimulated local IGF-1
expression and suppressed the elevated myostatin levels.
However, in view of the impaired IRS-1/PI3-kinase/Akt
signaling,19 it is unclear how this IGF-1 increase induces
muscle hypertrophy and whether IGF-1-independent
mechano-transduction might also play a role. Accordingly,
we postulated that the combination of exercise-induced local
production of IGF-1 and mechanically activated signal
transduction overrides the signaling defect and thereby
depresses the accelerated proteolysis, increases protein
synthetic capacity, and also cellular proliferation, resulting
in an increase in muscle mass.
To test our hypothesis, we increased the workload of the
plantaris muscle of one leg each in CRF and SN normal rats
for 7 days by excising the distal portion of the gastrocnemius
muscle and tendon with the contralateral plantaris serving as
a control. In the atrophied nonloaded CRF muscle, IRS-1 and
Akt phosphorylation were significantly depressed, a finding
consistent with Bailey et al.,19 who proposed that this
abnormality contributes to the muscle atrophy. In contrast,
we observed for the first time, that in CRF the IRS-1/
PI3-kinase/Akt signaling pathway can be fully activated by
increasing muscle workload. In both groups of rats, sustained
WO significantly increased several signaling protein levels
including the IGF-1 receptor, IRS-1, Akt, mTOR, and
p70S6K. Furthermore, key components of the IRS-1/
PI3-kinase/Akt signaling pathway were activated by tyrosine
phosphorylation. Phospho-IRS-1, phospho-Akt, phospho-
mTOR, and phospho-p70S6K levels all increased signifi-
cantly, and the CRF group values rose to levels comparable to
WO SN group values. Plantaris mass increased in both study
groups and at the end of the 7- day period were similar.
The mechanisms whereby mechanical stimuli induced by
WO activate the PI3-kinase/Akt pathway and cause muscle
hypertrophy are poorly understood.22 One key mechanism is
through GH-independent stimulation of local IGF-1 expres-
sion.9,10,23 Increased muscle work promotes local expression
of the IGF-1Ea mRNA transcript, the main form in liver, and
of a loading sensitive form, MGF, the IGF-1Eb mRNA
transcript in rodents.9,39 While the MGF C-terminal peptide
sequence differs from the common IGF-1 peptide sequence,
both forms stimulate muscle hypertrophy, though MGF
may be especially potent.9,10 Interestingly, basal IGF-1 and
MGF mRNA levels were similar in the SN and CRF rats, and
is consistent with cellular resistance to IGF-1/MGF as a cause
of muscle wasting. As described before,8 total IGF-1 mRNA
levels increased in WO muscle of CRF and SN rats, but in
addition, we noted that MGF levels increased too. This is
consistent with a role for local IGF-1 and MGF in mediating
the muscle hypertrophy observed.
Another key mechanism for WO-induced signal transduc-
tion involves mechanical activation of the downstream
components of the PI3-kinase/Akt pathway independent of
IGF-1.10,22 In this respect, we noted that in addition to an
increase in phosphorylation, the level of several signaling
proteins increased. To our knowledge, this is not a response
mediated by IGF-1, and we suggest that the signaling protein
increase may serve as another mechanism, whereby mecha-
nical stimuli enhance signaling. Of note, a similar response is
seen in nonuremic animals during recovery from a period of
immobilization.40 Thus, our findings suggest that IGF-1,
MGF, and mechanically induced signaling act together to
stimulate an increase in muscle mass in uremia.
Suppressor of cytokine signaling-2 is a member of a family
of proteins that inhibits GH signaling through the JAK/STAT
pathway41 and as it is elevated in CRF muscle, we suggested
that it is a cause of uremic GH resistance.8 There is also
recent evidence that SOCS2 can inhibit IGF-1 action and
does so by binding to the IGF-1 receptor and depressing
downstream signaling.32,42 In this study, we again found
increased SOCS2 expression in uremic muscle and propose
that this may be a cause of the suppressed basal IRS-1 and
Akt phosphorylation. It is noteworthy that SOCS2 expression
fell to normal control levels following an increase in
workload, and this may account for the normalization of
the work-induced signaling response noted. Unlike SOCS2,
basal SOCS3 levels were unaltered by CRF and rose to a
similar extent in WO plantaris muscle of CRF and normal
rats. An increase in muscle SOCS3 mRNA expression has
been described in rats undergoing endurance exercise
training and in the heart of pressure-overloaded rats.34,41,43
In addition to inhibiting cytokine-induced JAK-STAT
signaling, SOCS3 appears to interact with insulin and
IGF-1 signaling pathways,42,44,45 and also promotes myoblast
differentiation.43 However, the role played by SOCS3 in
exercise-induced muscle growth is unclear.
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In general, WO-induced muscle hypertrophy involves a
net increase in protein synthesis and increased satellite cell
proliferation, differentiation, and fusion with existing
myofibers.22,37,46 In this study, skeletal muscle total RNA
content, an indirect measure of total tissue ribosomal
content, and protein translational capacity35,36 increased
significantly in both the SN and CRF groups, reaching similar
levels. Muscle DNA content, an indirect measure of myo-
nuclear number,37 also increased and reached comparable
levels in both the groups. Thus, it appears that WO can
effectively enhance muscle protein synthetic capacity and
satellite cell proliferation, even in uremia.
Consistent with increased proteolysis as a cause of muscle
atrophy,4,29 we observed a fourfold increase in 14-kDa actin
fragment levels in nonloaded atrophied skeletal muscle of
CRF rats. Of note in WO muscle, the levels fell to values
comparable to that in nonuremic nonloaded muscle and is
consistent with a recent study of endurance exercise in end-
stage renal disease patients.29 As activation of the PI3-kinase/
Akt pathway suppresses caspase activity,25 the fall in fragment
level likely reflects WO activation of this pathway with
suppression of caspase activity and thus protein degradation.
This provides another mechanism whereby WO induces
muscle hypertrophy in uremia. Interestingly, muscle mRNA
expression of the E3-ligases atrogin and MuRF-1, which are
reported to be increased in uremic acidosis,47 was not
increased in our study. This likely reflects less severe renal
failure with absence of acidosis, for other components of the
ubiquitin–proteasome system that are also increased in
uremic acidosis, are not increased in the nonacidotic uremic
state.28,48 We suggest that the accumulation of 14- kDa actin
fragments in skeletal muscle of nonacidotic uremic rats
reflects an imbalance between the increased caspase activity
and the unchanged ubiquitin–proteasome system. Never-
theless, the increase in the fragment production by increasing
substrate availability, may enhance processing through the
ubiquitin–proteasome pathway.
In conclusion, this study provides new insight into the
mechanisms whereby resistance exercise induces muscle
hypertrophy in uremia. Our findings demonstrate that the
attenuated IRS-1/PI3-kinase/Akt signaling pathway in atro-
phied skeletal muscle of uremic rats can be effectively
activated by simply increasing muscle workload. This
response appears to be mediated by an increase in local
IGF-1 and MGF production and action, together with
mechanical enhancement of signal transduction. The latter
occurring, in part, due to an increase in signal protein level
and by suppression of SOCS2 expression. Indeed, the work-
induced signaling response was similar to that observed in
control rats and promoted changes consistent with a decrease
in muscle protein degradation, an increase in protein
synthetic capacity, and an increase in myonuclear number
that together appear to account for the increase in muscle
mass. Extrapolated clinically, this study provides an under-
standing of the cellular mechanisms involved in the beneficial
effect of resistance exercise in patients with CRF and
reinforces the value of exercise in the management of
advanced CRF patients.
MATERIALS AND METHODS
Experimental animals and protocols
Twenty-two Male Sprague–Dawley rats weighing B260 g were
studied. CRF was created by a two-step 5/6 nephrectomy procedure
in rats anesthetized with ketamine (80 mg kg1) and xylazine
(10 mg kg1) as described before.8 Sham nephrectomy (SN)
operations were performed on animals that were then fed a daily
food allowance equal to the average amount of food consumed by
the CRF rats the previous day. Fourteen days later, the CRF and SN
rats underwent surgery to produce unilateral WO of the plantaris
muscle as described before.8,13 In short, under ketamine and
xylazine anesthesia the distal tendon of gastrocnemius muscle of one
leg and adjacent one-third of that muscle was excised. No surgery
was performed on the contralateral limb, which served as a paired
control. Seven days later, the rats were anesthetized and the plantaris
muscle excised, weighed, and stored at 801C. Serum was collected,
and creatinine and CO2 levels were measured. Animal protocols
were approved by the Local Institutional Animal Care and Use
Committee.
Real-time quantitative RT-PCR assay
Real-time quantitative reverse transcription (RT)-PCR with SYBR
green dye was performed as described before8 using the ABI Prism
7900 Sequence Detection System (Applied Biosystems, Foster City,
CA, USA) and protocols from the manufacturer. Primers for
quantitation of total IGF-1 (all splice variants), MGF, atrogin-1/
MAFbx, MuRF-1, SOCS2 and SOCS3, and the internal control gene
ribosomal 18S (Table 3) were designed with the primer design
software Primer Express (Applied Biosystems) and synthesized by
Operon Biotechnology (Huntsville, AL, USA). The MGF primers
encompassed the 52-bp insert unique to MGF (IGF-1Eb in
Table 3 | Primer sequences for real-time quantitative PCR analysis
Forward (50–30) Reverse (50–30)
18S GGAAGCTTAGAGGAGCGAGCGACC GGGAATTCCTGCCAGTAGCATATGCTTG
SOCS2 TGAGCTCAGTCAAACAGGATGGTAC ATAGGTAGTCTGAGTGGGAGCTATC
SOCS3 CAGCTCCAAGAGCGAGTACA CGGTTACGGCACTCCAGTAGA
IGF-1 CCGCTGCAAGCCTACAAAGT TGAGTCTTGGGCATGTCAGTGT
MGF CACTGACATGCCCAAGACTCA TCTCCTTTGCAGCTTCCTTTTC
MGF probe AAGTCCCAGCCCCTATCGACACAC
Atrogin-1 AGAAAAGCGGCACCTTCGT CTTGGCTGCAACATCGTAGTTC
MuRF-1 GTGAAGTTGCCCCCTTACAA TGGAGATGCAATTGCTCAGT
IGF-1, insulin-like growth factor-1; MGF, mechano growth factor; SOCS, suppressor of cytokine signaling.
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the rat).49 Total RNA was extracted from plantaris muscle and used
for cDNA synthesis by reverse transcription (Applied Biosystems)
and the cDNA samples were subjected to PCR analysis. Results were
quantified using the relative standard curve method. An internal
control gene standard curve was also generated and the target gene
normalized for this endogenous control. Each sample was analyzed
in triplicate in individual assays performed on two or more
occasions.
Western immunoblotting
The IGF-1Rb antibody and the Akt antibody, which mainly detects
Akt-1 and to a lesser extent Akt-2 and -3, were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). p85, phospho-IRS-1, and
actin antibodies were from Upstate Biotechnology (Lake Placid, NY,
USA) and BioSource (Camarillo, CA, USA) and Sigma-Aldrich (St
Louis, MO, USA), respectively. IRS-1, mTOR, p70S6 kinase,
phospho-IGF-1R (Tyr1131)/IR (Tyr1146), phospho-Akt (Thr308),
phospho-mTOR (Ser2448), and phospho-p70S6 kinase (Thr389)
antibodies were from Cell Signaling Technology Inc. (Danvers, MA,
USA). Lysates were prepared from frozen muscle and used for
western immunoblot analysis as described before,50 with the
exception of samples for the analysis of the 14-kDa actin fragment.
These were prepared as described,29 in brief, muscle homogenates
prepared in the presence of protease inhibitors were centrifuged at
3300 g for 10 min, and the pellet suspended and boiled in Laemmli
sample buffer for analysis. Most proteins were separated by
electrophoresis on a 7.5% SDS polyacrylamide gel, except for
mTOR and the 14-kDa actin fragment. For detecting the 289-kDa
mTOR protein a 4B20% Tris-Glycine gel from Invitrogen
(Carlsbad, CA, USA) was used; the actin fragment was separated
on a 15% SDS gel. Proteins separated in the gels were electroblotted
onto nitrocellulose membranes and then immunodetected with
appropriate antibodies and visualized by enhanced chemilumines-
cence, as described before.50 Protein expression was quantitated with
Image Quant 5.2 software (Molecular Dynamics) from Amersham
Biosciences (Piscataway, NJ, USA).
Biochemistry
Muscle protein content was assayed by the Bradford method
(Bio-Rad Laboratories, Hercules, CA, USA), and serum creatinine,
urea nitrogen, and CO2 levels with a Beckman LX 20 Analyzer
(Beckman Coulter Inc., Fullerton, CA, USA). Total RNA was isolated
from homogenized muscle with Sigma TRI-reagent (Sigma-Aldrich)
and measured at 260 nm with a UV/visible spectrophotometer
(Ultrospec 3000; Pharmacia Biotech, Cambridge, UK). DNA was
extracted from tissue homogenate with a DNeasy Blood and Tissue
kit (Qiagen Sciences, Valencia, CA, USA). RNA-free genomic DNA
was achieved by adding RNase A to eliminate RNA contamination.
DNA yield was determined by measuring the concentration of DNA
in the elute by its absorbance at 260 nm, and RNA and DNA content
were calculated from the product of the measured concentration and
whole muscle weight.
Data analysis and statistics
Specific mRNAs were normalized for the internal control gene and
were expressed as transcript/housekeeping gene ratios. Mean protein
and phosphoprotein levels measured in the control nonloaded
plantaris muscle of the SN normal rats were assigned values of 100,
and individual levels are expressed relative to this value. Data are
given as mean±s.e.m. Two-tailed unpaired Student’s t-tests were
applied for comparison of two normally distributed groups.
Where appropriate, paired t-tests were applied to compare left and
right plantaris muscles from the same animal; comparisons between
more than two normally distributed groups were made by one-way
analysis of variance followed by pairwise multiple comparison with
the Holms t-test.51 A P-value o0.05 was considered statistically
significant.
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